AU2019218315A1 - Codon optimized precursor gene and signal peptide gene of human insulin analogue - Google Patents

Codon optimized precursor gene and signal peptide gene of human insulin analogue Download PDF

Info

Publication number
AU2019218315A1
AU2019218315A1 AU2019218315A AU2019218315A AU2019218315A1 AU 2019218315 A1 AU2019218315 A1 AU 2019218315A1 AU 2019218315 A AU2019218315 A AU 2019218315A AU 2019218315 A AU2019218315 A AU 2019218315A AU 2019218315 A1 AU2019218315 A1 AU 2019218315A1
Authority
AU
Australia
Prior art keywords
nucleic acid
acid molecule
glu
seq
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019218315A
Other languages
English (en)
Inventor
Lei Chen
Feifei Wang
Hongwei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hengrui Medicine Co Ltd
Original Assignee
Jiangsu Hengrui Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co Ltd filed Critical Jiangsu Hengrui Medicine Co Ltd
Publication of AU2019218315A1 publication Critical patent/AU2019218315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/84—Pichia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2019218315A 2018-02-09 2019-02-01 Codon optimized precursor gene and signal peptide gene of human insulin analogue Abandoned AU2019218315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810131794 2018-02-09
CN201810131794.3 2018-02-09
PCT/CN2019/074384 WO2019154311A1 (zh) 2018-02-09 2019-02-01 一种密码子优化的人胰岛素类似物前体基因和信号肽基因

Publications (1)

Publication Number Publication Date
AU2019218315A1 true AU2019218315A1 (en) 2020-07-09

Family

ID=67548783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019218315A Abandoned AU2019218315A1 (en) 2018-02-09 2019-02-01 Codon optimized precursor gene and signal peptide gene of human insulin analogue

Country Status (12)

Country Link
US (1) US20210032307A1 (https=)
EP (1) EP3750998A4 (https=)
JP (1) JP2021513330A (https=)
KR (1) KR20200119237A (https=)
CN (1) CN111094572B (https=)
AU (1) AU2019218315A1 (https=)
BR (1) BR112020015238A2 (https=)
CA (1) CA3086618A1 (https=)
MX (1) MX2020007929A (https=)
RU (1) RU2020128190A (https=)
TW (1) TW201934752A (https=)
WO (1) WO2019154311A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111560379B (zh) * 2020-05-26 2022-09-13 北京惠之衡生物科技有限公司 密码子优化的门冬胰岛素前体基因、重组载体、基因工程菌及其应用
CN116751817B (zh) * 2023-05-29 2024-07-09 广东东阳光药业股份有限公司 检测胰岛素或其类似物的生物学活性的方法及试剂盒
CN117384275B (zh) * 2023-12-13 2024-03-15 北京科为博生物科技有限公司 胰岛素样生长因子突变体igf1m及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
EP1132404A3 (en) 1993-09-17 2002-03-27 Novo Nordisk A/S Acylated insulin
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
ES2258797T3 (es) * 1996-12-20 2006-09-01 Novo Nordisk A/S Proteinas con extension n-terminal expresadas en la levadura.
CN1302333A (zh) * 1998-01-23 2001-07-04 诺沃挪第克公司 在酵母中制备目的多肽的方法
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
PL1633876T3 (pl) * 2003-06-17 2009-01-30 Sembiosys Genetics Inc Sposoby wytwarzania insuliny w roślinach
CA2531988C (en) 2003-08-05 2016-06-28 Novo Nordisk A/S Novel insulin derivatives
CN1873006A (zh) * 2005-05-30 2006-12-06 上海新生源医药研究有限公司 一种重组人胰岛素原的生产方法
MY161552A (en) * 2009-03-12 2017-04-28 Bigtec Private Ltd A polynucleotide and polypeptide sequence and methods thereof
AR087433A1 (es) * 2011-08-08 2014-03-26 Merck Sharp & Dohme Analogos de insulina n-glicosilados
KR20140104994A (ko) * 2011-12-15 2014-08-29 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 인간 인슐린 유사체 및 이의 아실화 유도체
WO2018024186A1 (zh) 2016-08-02 2018-02-08 江苏恒瑞医药股份有限公司 一种人胰岛素或其类似物的酰化衍生物

Also Published As

Publication number Publication date
JP2021513330A (ja) 2021-05-27
EP3750998A4 (en) 2022-02-23
RU2020128190A3 (https=) 2022-03-09
MX2020007929A (es) 2020-10-01
BR112020015238A2 (pt) 2020-12-29
CA3086618A1 (en) 2019-08-15
KR20200119237A (ko) 2020-10-19
TW201934752A (zh) 2019-09-01
CN111094572B (zh) 2023-04-04
US20210032307A1 (en) 2021-02-04
CN111094572A (zh) 2020-05-01
WO2019154311A1 (zh) 2019-08-15
RU2020128190A (ru) 2022-03-09
EP3750998A1 (en) 2020-12-16

Similar Documents

Publication Publication Date Title
US5635604A (en) Amino-terminally extended human growth hormone (HGH)
CN110724187B (zh) 一种高效表达利拉鲁肽前体的重组工程菌及其应用
JP7266325B2 (ja) 蛍光タンパク質フラグメントを含む融合タンパク質およびその用途
AU2019218315A1 (en) Codon optimized precursor gene and signal peptide gene of human insulin analogue
JPH0847393A (ja) 酵母からタンパク質を分泌させるためのシグナル配列
US10000544B2 (en) Process for production of insulin and insulin analogues
KR100659671B1 (ko) 신규한 융합단백질로부터 재조합 인슐린을 제조하는 방법
CN116554309A (zh) 一种重组人源ⅲ型胶原蛋白及其制备方法和应用
US20210230659A1 (en) Leader Sequence for Higher Expression of Recombinant Proteins
CN114686504B (zh) Lpp或其突变体作为分子伴侣在大肠杆菌中分泌表达重组蛋白的应用
JP2022548598A (ja) 組換え治療用ペプチドの発現のためのｎ末端伸長配列
CN114805610B (zh) 一种高表达甘精胰岛素前体的重组基因工程菌及其构建方法
HK40025349A (en) Codon optimized precursor gene and signal peptide gene of human insulin analogue
RU2263147C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pHINS05, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, КЛЕТКА ESCHERICHIA COLI, ТРАНСФОРМИРОВАННАЯ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК pHINS05, И ШТАММ БАКТЕРИЙ ESCHERICHIA COLI JM109/pHINS05 - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
Rao et al. Expression, purification, and characterisation of nesiritide using an E. coli expression system
CN111197041B (zh) 制备青鳉鱼肠激酶活性亚基的方法、其产物和用途
US7638618B2 (en) Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
RU2515061C1 (ru) РЕКОМБИНАТНАЯ ПЛАЗМИДНАЯ ДНК рНI03 КОДИРУЮЩАЯ, ГИБРИДНЫЙ БЕЛОК С ПРОИНСУЛИНОМ ЧЕЛОВЕКА, КЛЕТКА Escherichia coli, ТРАНСФОРМИРОВАННАЯ РЕКОМБИНАНТНОЙ ПЛАЗМИДНОЙ ДНК рНI03, И ШТАММ БАКТЕРИЙ Escherichia coli JM109/pHI03-ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА-ПРЕДШЕСТВЕННИКА ИНСУЛИНА ЧЕЛОВЕКА
CN118373922A (zh) 可溶性的标签蛋白在制备司美格鲁肽主链中的应用
CN104672334B (zh) 重组长链人胰岛素样生长因子-i的制备方法
WO2013149729A2 (en) Proinsulin with enhanced helper sequence
CN121974995A (en) Polypeptide for promoting soluble expression of GLP-1 analogue precursor polypeptide and application thereof
HK40072579B (zh) 一种胰岛素或其类似物前体

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period